s6y
Company name or ticker
Search
Checkpoint Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Monday, April 30, 2018
Period
Jun 13, 2018
Accession number
0001144204-18-023424
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header